Weight loss · Kansas
Weight loss and obesity studies in Kansas
20 studies have at least one recruiting site in Kansas. Weight-management research includes trials of new medicines, devices, diets and lifestyle programs for people with overweight or obesity, and studies of weight-related conditions such as fatty liver disease.
20 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
2 studies with pay posted
Exact amounts posted by the research company for each study. The button opens that study’s own page.
Pays up to
$10,500
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Participants
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 6 nights and 6 outpatient visits.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
Pays up to
$7,750
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Volunteers
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 13 nights and 1 follow-up visit.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
More recruiting studies (pay not posted)
- RecruitingHealthy volunteersPhase 1
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Wichita, KS + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Wichita, KS + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron Pharmaceuticals
- Location
- Wichita, KS + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Topeka, KS + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Newton, KS + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- Topeka, KS + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- Topeka, KS + 42 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Amgen
- Location
- Lenexa, KS + 30 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- Lenexa, KS + 69 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Novo Nordisk A/S
- Location
- Topeka, KS + 26 other US sites
- Eligibility basics
- Ages 8–18
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Eli Lilly and Company
- Location
- Topeka, KS + 40 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Eli Lilly and Company
- Location
- Topeka, KS + 55 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
AstraZeneca
- Location
- Lenexa, KS + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Kansas City, KS + 117 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Topeka, KS + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Overland Park, KS + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
- Location
- El Dorado, KS + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Gestational Response, Outcomes, and Weight After GLP-1 Use
University of Kansas Medical Center
- Location
- Kansas City, KS
- Eligibility basics
- Ages 18–45 · Women only
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Can I join a weight loss study if I already take a GLP-1 medicine?
It depends on the study. Many exclude people currently or recently on weight-loss medicines; others are designed specifically for them. The listing’s eligibility criteria and the study team are the only reliable answer.